Details
Stereochemistry | ACHIRAL |
Molecular Formula | C25H27N9 |
Molecular Weight | 453.5422 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
Stereo Comments | Substituted ring |
SHOW SMILES / InChI
SMILES
CN1N=NC(=N1)C2=CC3=C(C=C2)C4=C(N[C@H]5CC[C@H](N)CC5)N=C(CC6=CC=CC=C6)N=C4N3
InChI
InChIKey=AZXXGVPWWKWGAE-IYARVYRRSA-N
InChI=1S/C25H27N9/c1-34-32-23(31-33-34)16-7-12-19-20(14-16)28-25-22(19)24(27-18-10-8-17(26)9-11-18)29-21(30-25)13-15-5-3-2-4-6-15/h2-7,12,14,17-18H,8-11,13,26H2,1H3,(H2,27,28,29,30)/t17-,18-
Molecular Formula | C25H27N9 |
Molecular Weight | 453.5422 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/25237102Curator's Comment: description was created based on several sources, including
http://www.google.com/patents/WO2013110198A1 | https://www.ncbi.nlm.nih.gov/pubmed/28330619 | https://www.ncbi.nlm.nih.gov/pubmed/27337543 | https://clinicaltrials.gov/ct2/show/study/NCT02668315
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25237102
Curator's Comment: description was created based on several sources, including
http://www.google.com/patents/WO2013110198A1 | https://www.ncbi.nlm.nih.gov/pubmed/28330619 | https://www.ncbi.nlm.nih.gov/pubmed/27337543 | https://clinicaltrials.gov/ct2/show/study/NCT02668315
UM171 is a potent agonist of human hematopoietic stem cell renewal, independently of AhR suppression. UM171 act differently than other small molecule stimulators of hematopoiesis, such as the aryl hydrocarbon receptor (AhR) antagonist StemRegenin 1 (SR1). Addition of UM171 to cultures containing SR1 and cytokines further enhances the ex vivo expansion of normal HSCs, including CD34+ cells.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: WP2849 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27337543 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25237102
CD34+ cells isolated from cord blood (CB) were cultured in a fed-batch (FB) system for 12 days in the presence of cytokines and UM171 [35 nM], SR1 [750 nM] or the combination of both UM171 [35 nM] and SR1 [500 nM].
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 14:13:03 GMT 2023
by
admin
on
Sat Dec 16 14:13:03 GMT 2023
|
Record UNII |
8XZ4J0KS9C
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
300000009941
Created by
admin on Sat Dec 16 14:13:03 GMT 2023 , Edited by admin on Sat Dec 16 14:13:03 GMT 2023
|
PRIMARY | |||
|
1448724-09-1
Created by
admin on Sat Dec 16 14:13:03 GMT 2023 , Edited by admin on Sat Dec 16 14:13:03 GMT 2023
|
PRIMARY | |||
|
8XZ4J0KS9C
Created by
admin on Sat Dec 16 14:13:03 GMT 2023 , Edited by admin on Sat Dec 16 14:13:03 GMT 2023
|
PRIMARY | |||
|
DTXSID201108994
Created by
admin on Sat Dec 16 14:13:03 GMT 2023 , Edited by admin on Sat Dec 16 14:13:03 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
UM171 could significantly expand human cord blood HSCs ex vivo with the help of their newly developed automated and continuous medium delivery system
|